BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20250903T064705EDT-6278SDIusT@132.216.98.100
DTSTAMP:20250903T104705Z
DESCRIPTION:Le Groupe de recherchen en santé et droit de 91ºÚÁÏÍø (GRSD) et l
 'Institut de recherche sur les politiques sociales et de santé (IRPS) sont
  fiers d'accueuillir Thomas Pogge pour la 6e conférence annuelle du GRSD. 
  Le professeur Thomas Pogge dirige le Programme de justice globale et est 
 titulaire de la chaire Leitner en philosophie et en affaire internationale
 s à l'Université Yale.  La conférence est gratuite et ouverte au public. T
 outefois\, comme le nombre de places est limité\, nous vous prions de rése
 rver votre place en écrivant à rghl.law [at] mcgill.ca.  Cette activité es
 t accréditée par le Barreau du Québec pour 1\,5 heures de formation contin
 ue pour juristes (activité no. 10075976). Prière d'indiquer si vous êtes m
 embre du Barreau dans votre RSVP.  Résumé   (En anglais seulement). One-th
 ird of all human lives end in early death from poverty-related causes. Man
 y of these premature deaths are avoidable through global health system ref
 orms\, including to the existing patent regime. The latter provides incent
 ives for the development and distribution of new medicines\; but it also l
 eaves gaps\, especially in poor regions. The Health Impact Fund (HIF) is a
  mechanism intended to fill these gaps and to improve access to new medici
 nes worldwide.  The HIF would give pharmaceutical innovators the option to
  be rewarded according to the incremental health impact of their product r
 ather than through a patent-protected mark-up. The HIF would stimulate the
  development of high-impact medicines (especially for currently neglected 
 diseases)\, would ensure availability at low cost\, and would encourage in
 novators to market such medicines with the aim of reducing the global dise
 ase burden.  The feasibility of this reform shows that the existing medica
 l-patent regime is severely unjust. Professor Pogge will (a) introduce the
  HIF proposal and its moral justification\, (b) discuss its implementation
 \, funding\, and economic viability\, (c) explain its advantages for pharm
 aceutical firms as well as the benefits for the health and welfare of affl
 uent and poor populations and (d) report on efforts to pilot the HIF idea 
 in particular jurisdictions.  Le conférencier   (En anglais seulement). Ha
 ving received his PhD in philosophy from Harvard\, Thomas Pogge is Leitner
  Professor of Philosophy and International Affairs and Director of the Glo
 bal Justice Program at Yale. He is a member of the Norwegian Academy of Sc
 ience as well as President of Academics Stand Against Poverty (ASAP)\, an 
 international network aiming to enhance the impact of scholars\, teachers 
 and students on global poverty\, and of Incentives for Global Health\, a t
 eam effort toward developing a complement to the pharmaceutical patent reg
 ime that would improve access to advanced medicines for the poor worldwide
  (www.healthimpactfund.org). Pogge's recent publications include Politics 
 as Usual (Polity 2010)\; World Poverty and Human Rights (Polity 2008)\; Jo
 hn Rawls: His Life and Theory of Justice (Oxford 2007)\; and Freedom from 
 Poverty as a Human Right (Oxford & UNESCO 2007).
DTSTART:20131011T183000Z
DTEND:20131011T200000Z
LOCATION:Maxwell Cohen Moot Court (room 100)\, Pavillon Chancellor-Day\, CA
 \, QC\, Montréal\, H3A 1W9\, 3644\, rue Peel
SUMMARY:Conférence annuelle GRSD/IRPC avec Thomas Pogge: Payer pour le 'Hea
 lth Impact Fund'
URL:/law/fr/channels/event/conference-annuelle-grsdirp
 c-avec-thomas-pogge-payer-pour-le-health-impact-fund-22988
END:VEVENT
END:VCALENDAR